Detalles de la búsqueda
1.
Revealing uncertainty in the status of biodiversity change.
Nature
; 628(8009): 788-794, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38538788
2.
Retinoids in the treatment of photoageing: A histological study of topical retinoid efficacy in black skin.
J Eur Acad Dermatol Venereol
; 2024 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38682699
3.
Health-Related Quality of Life Following Simultaneous Resection for Synchronous Colorectal Cancer Liver Metastases.
Ann Surg Oncol
; 30(3): 1331-1338, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36350458
4.
Physical activity is important for cardiovascular health and cardiorespiratory fitness in patients with psoriasis.
Clin Exp Dermatol
; 47(2): 289-296, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34368977
5.
The promise and challenges of cell therapy for psoriasis.
Br J Dermatol
; 185(5): 887-898, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34036569
6.
Systematic review examining changes over time and variation in the incidence and prevalence of psoriasis by age and gender.
Br J Dermatol
; 184(2): 243-258, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32358790
7.
Risk of hospitalization and death due to infection in people with psoriasis: a population-based cohort study using the Clinical Practice Research Datalink.
Br J Dermatol
; 184(1): 78-86, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32222069
8.
Alcohol misuse is associated with poor response to systemic therapies for psoriasis: findings from a prospective multicentre cohort study.
Br J Dermatol
; 185(5): 952-960, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34128222
9.
Patient preferences for stratified medicine in psoriasis: a discrete choice experiment.
Br J Dermatol
; 185(5): 978-987, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33991338
10.
The risk of malignancy in patients with secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis: analysis of clinical trial and postmarketing surveillance data with up to five years of follow-up.
Br J Dermatol
; 185(5): 935-944, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33829482
11.
Five-year maintenance of clinical response and health-related quality of life improvements in patients with moderate-to-severe psoriasis treated with guselkumab: results from VOYAGE 1 and VOYAGE 2.
Br J Dermatol
; 185(6): 1146-1159, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34105767
12.
Efficacy of secukinumab and adalimumab in patients with psoriatic arthritis and concomitant moderate-to-severe plaque psoriasis: results from EXCEED, a randomized, double-blind head-to-head monotherapy study.
Br J Dermatol
; 185(6): 1124-1134, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33913511
13.
Defining trajectories of response in patients with psoriasis treated with biologic therapies.
Br J Dermatol
; 185(4): 825-835, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33829489
14.
A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 24-week efficacy and safety results from a randomized, double-blinded trial.
Br J Dermatol
; 184(6): 1047-1058, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32880909
15.
Risk-mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey.
Br J Dermatol
; 185(1): 80-90, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33368145
16.
Anakinra for palmoplantar pustulosis: results from a randomized, double-blind, multicentre, two-staged, adaptive placebo-controlled trial (APRICOT).
Br J Dermatol
; 2021 Aug 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34411292
17.
Investigating the environmental, behavioural, and sociodemographic determinants of attendance at a city-wide public health physical activity intervention: Longitudinal evidence over one year from 185,245 visits.
Prev Med
; 143: 106334, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33227345
18.
Research priorities and identification of a health-service delivery model for psoriasis from the UK Psoriasis Priority Setting Partnership.
Clin Exp Dermatol
; 46(2): 276-285, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32748405
19.
The incidence of psoriasis in Chile: an analysis of the National Waiting List Repository.
Clin Exp Dermatol
; 46(7): 1262-1269, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33914930
20.
Twelve-week secukinumab treatment is consistently efficacious for moderate-to-severe psoriasis regardless of prior biologic and non-biologic systemic treatment: Post hoc analysis of six randomised trials.
J Eur Acad Dermatol Venereol
; 35(4): 928-937, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33030755